Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity [ATAC-seq1]

ABSTRACT: ATAC-seq profiling of WT and OPA1-deficient cDC1s

ORGANISM(S): Mus musculus

PROVIDER: GSE285345 | GEO | 2026/04/21

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity [microarray2]

Project description:Transcriptional dissection of splenic WT and OPA1-deficient cDC1s

2026-01-26 | GSE285155 | GEO

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity [ATAC-seq2]

Project description:ATAC-seq profiling of intratumoral cDC1s

2026-01-26 | GSE304687 | GEO

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity [microarray1]

Project description:Transcriptional dissection of cDC1s with polarized mitochondria or cDC1s with depolarized mitochondria

2026-01-26 | GSE285156 | GEO

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity [microarray3]

Project description:Transcriptional dissection of intratumoral cDC1s

2026-01-26 | GSE304510 | GEO

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity [ATAC-seq1]

Project description:Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity [ATAC-seq1]

| PRJNA1203209 | ENA

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity

Project description:This SuperSeries is composed of the SubSeries listed below.

2026-01-21 | GSE285346 | GEO

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity [ATAC-seq2]

Project description:Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity [ATAC-seq2]

| PRJNA1302328 | ENA

DYRK1A enhances antitumor immunity in type 1 conventional dendritic cells via mTORC1 activation

Project description:Type 1 conventional dendritic cells (cDC1s) play an integral role in mediating immune responses and maintaining homeostasis, yet the molecular mechanisms underlying their functions remain poorly understood. In this study, we identify dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) as a key kinase that responds to TLR and growth factor stimulation, acting as an essential regulator of cDC1 function. Genetic ablation of Dyrk1a specifically in cDC1s impairs antitumor immunity and accelerates tumor progression in murine models. Mechanistically, DYRK1A mediates the phosphorylation of the mTORC1 inhibitor TSC2 at serine 540, triggering the degradation of TSC2 and promoting the mTORC1 signaling in cDC1s. Notably, Tsc2 deletion in Dyrk1a-deficient cDC1s remarkably restores their antitumor immune functions. Furthermore, DYRK1A-mediated mTORC1 signaling in cDC1s positively correlates with effector T-cell responses across multiple human cancers. Our findings highlight a critical role for the DYRK1A-TSC2-mTORC1 signaling pathway in regulating cDC1 functions in antitumor immunity, offering potential strategies to improve cancer immunotherapy.

2026-04-01 | GSE281370 | GEO

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity

Project description:Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity

| PRJNA1203201 | ENA

DYRK1A enhances antitumor immunity in type 1 conventional dendritic cells via mTORC1 activation [tumor-infiltrating type 1 conventional dendritic cells]

Project description:Type 1 conventional dendritic cells (cDC1s) play an integral role in mediating immune responses and maintaining homeostasis, yet the molecular mechanisms underlying their functions remain poorly understood. In this study, we identified dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) as a key kinase that responded to TLR and growth factor stimulation and acted as an essential regulator of cDC1 function. Genetic ablation of Dyrk1a specifically in cDC1s impaired antitumor immunity and accelerated tumor progression in murine models. Mechanistically, DYRK1A mediated the phosphorylation of the mTORC1 inhibitor TSC2 at serine 540, triggering the degradation of TSC2 and promoting the mTORC1 signaling in cDC1s. Notably, Tsc2 deletion in Dyrk1a-deficient cDC1s remarkably restored their antitumor immune functions. Furthermore, DYRK1A-mediated mTORC1 signaling in cDC1s positively correlated with effector T-cell responses across multiple human cancers. Our findings highlight a critical role for the DYRK1A-TSC2-mTORC1 signaling pathway in regulating cDC1 functions in antitumor immunity, offering potential strategies to improve cancer immunotherapy.

2026-04-10 | GSE327455 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data